Skip to content

13F-HR filed by Lumina Fund Management LLC

Lumina Fund Management LLC filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 32 holding rows worth $264,255,000.

Accession
0001511847-21-000002
Filed
2021-05-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 32 entries on the cover page, a total value of $264,255,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $264,255,000 with VALUE read as thousands by filing date, 13F file number 028-14205. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS351,001$139,112,000thousands by filing date
SPY78462F103SHS200,000$76,400,000thousands by filing dateput
INVESCO QQQ TR46090E103COM45,100$14,393,000thousands by filing date
Apple Inc037833100COM64,000$7,818,000thousands by filing date
NXP SEMICONDUCTORS N V COMN6596X109Stock11,500$2,315,000thousands by filing date
Qualcomm Incorporated747525103COM15,300$2,029,000thousands by filing date
CVS Health Corporation126650100COM25,300$1,903,000thousands by filing date
Amgen Inc.031162100COM6,500$1,617,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM3,200$1,460,000thousands by filing date
PARAMOUNT GLOBAL92556H206CLASS B COM31,925$1,440,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS6,200$1,406,000thousands by filing date
Broadcom Inc.11135F101COM3,000$1,391,000thousands by filing date
Vanguard High Dividend Yield ETF921946406SHS13,702$1,385,000thousands by filing date
Pfizer Inc.717081103COM30,000$1,087,000thousands by filing date
Merck & Co.,Inc.58933Y105COM12,500$964,000thousands by filing date
ILLUMINA INC452327109COM2,500$960,000thousands by filing date
Bristol-Myers Squibb Company110122108COM15,000$947,000thousands by filing date
MasterCard, Inc57636Q104COM2,500$890,000thousands by filing date
BIOGEN INC COM09062X103Stock3,100$867,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock1,800$852,000thousands by filing date
BAIDU INC SPON ADR REP A056752108ADR3,500$761,000thousands by filing date
SCIENCE APPLICATIONS INTL CORP COM808625107Stock8,500$711,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM4,100$627,000thousands by filing date
EURONET WORLDWIDE INC COM298736109Stock4,500$622,000thousands by filing date
INMODE LTD SHSM5425M103Stock8,000$579,000thousands by filing date
LIONS GATE ENTMNT CORP535919401CL A VTG30,000$449,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock15,000$442,000thousands by filing date
VIATRIS INC COM92556V106Stock20,000$279,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR3,000$231,000thousands by filing date
Palantir Technologies Inc. Class A69608A108COM5,000$116,000thousands by filing date
ABCELLERA BIOLOGICS INC COM00288U106Stock3,000$102,000thousands by filing date
ASANA INC04342Y104CL A3,500$100,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001511847-21-000002this filing2021-05-17acceptance time not in the bulk data set